According to a meta-analysis of 1226 East Asian NSCLC patients [68], compared with tumor tissues, the comprehensive sensitivity and specificity of detecting EGFR gene mutation in pleural effusion samples were 0.86 and 0.93, respectively. This evidence concerns the gene EGFR and non-small cell lung carcinoma.